10-Apr-2026
Globe Newswire (Fri, 10-Apr 8:15 AM ET)
LifeMD Offers Novo Nordisk's Industry-First Wegovy Telehealth Subscription Program
Globe Newswire (Tue, 31-Mar 8:45 AM ET)
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
Globe Newswire (Tue, 24-Mar 4:05 PM ET)
Globe Newswire (Mon, 16-Mar 8:00 AM ET)
Market Chameleon (Tue, 10-Mar 6:32 AM ET)
LifeMD Reports Fourth Quarter and Full Year 2025 Results
Globe Newswire (Mon, 9-Mar 4:05 PM ET)
LifeMD to Participate in Two Investor Conferences During March
Globe Newswire (Tue, 3-Mar 4:05 PM ET)
LifeMD to Report Fourth Quarter 2025 Financial Results on March 9
Globe Newswire (Mon, 23-Feb 8:00 AM ET)
Globe Newswire (Thu, 5-Feb 10:45 AM ET)
Kuehn Law Encourages Investors of LifeMD, Inc. to Contact Law Firm
Globe Newswire (Wed, 28-Jan 12:53 PM ET)
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.
Lifemd trades on the NASDAQ stock market under the symbol LFMD.
As of April 10, 2026, LFMD stock price climbed to $3.47 with 968,613 million shares trading.
LFMD has a beta of 1.08, meaning it tends to be more sensitive to market movements. LFMD has a correlation of 0.04 to the broad based SPY ETF.
LFMD has a market cap of $166.47 million. This is considered a Micro Cap stock.
Last quarter Lifemd reported $47 million in Revenue and -$.04 earnings per share. This beat revenue expectation by $2 million and missed earnings estimates by -$.06.
In the last 3 years, LFMD traded as high as $15.84 and as low as $1.40.
The top ETF exchange traded funds that LFMD belongs to (by Net Assets): IWM, VTI, VXF, KOMP, IWO.
LFMD has underperformed the market in the last year with a price return of -30.3% while the SPY ETF gained +30.9%. LFMD has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -10.1% and -6.7%, respectively, while the SPY returned -1.8% and +7.2%, respectively.
LFMD support price is $3.22 and resistance is $3.58 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LFMD shares will trade within this expected range on the day.